Latest Strategy News

FBR Limited has secured a pivotal engineering agreement with Samsung Heavy Industries to develop a shipbuilding automation robot, marking a significant step in industrial robotics innovation.

Zenith Minerals Limited has had its trading suspension lifted immediately following the release of a rights issue announcement, signaling a key capital raising move.

Zenith Minerals has launched a fully underwritten A$3.5 million entitlement offer to fund an aggressive drilling campaign at its newly consolidated Dulcie Gold Project and advance exploration at Red Mountain. The capital raise aims to expand resources and push towards commercial gold production.

PointsBet Holdings has formalised a conditional takeover bid deed with MIXI at $1.20 per share, activating if shareholders reject the current scheme of arrangement. The deal hinges on key regulatory approvals and a minimum 50.1% acceptance threshold.

Unico Silver Limited has reported its highest silver intercept to date at the Cerro Leon project, delivering significant near-surface and deeper mineralisation that underpins its dual-track growth strategy.

Harvest Technology Group’s CEO, Ilario Faenza, has stepped in with a $500,000 unsecured loan to support the company’s working capital, highlighting ongoing liquidity management efforts.

Nimy Resources reports impressive high-grade gallium assay results from initial Phase 2 drilling at its Block 3 project in Western Australia, reinforcing its potential as a standalone gallium source.

Southern Cross Gold Consolidated Ltd reports exceptional high-grade gold and antimony results from its Sunday Creek project, including a remarkable 3.9-meter intercept grading 124.6 g/t gold and assays reaching 2,110 g/t. The findings validate the company's systematic infill drilling strategy and reveal new mineralized zones, enhancing the project's strategic value amid global antimony supply constraints.

Toubani Resources has initiated a 5,000-metre diamond drilling campaign at its Kobada Gold Project in Mali, targeting deeper mineralisation to expand its 2.2 million ounce resource and extend mine life.

Nyrada’s Phase I clinical trial for its novel drug Xolatryp has cleared safety reviews through four cohorts and will now test higher doses and longer infusions in an expanded trial design.

EVE Health Group’s subsidiary Nextract has inked a pivotal two-year agreement with TeleDocs Clinic, enabling nationwide online prescribing of its upcoming erectile dysfunction and dysmenorrhea products ahead of regulatory approval.

IRIS Metals has reported promising high-grade lithium intersections from its Phase I drilling at the Edison Project in South Dakota, reinforcing its strategy to develop a centralized lithium processing hub in the US.